Stock detail
Cormedix (CRMD) stock price, chart, and key data
View Cormedix stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Cormedix
CRMD · XNAS
$7.64
-6.83%
-$0.56
Pre-market $7.50 (-1.83%)
Key metrics
52-week range
$1.25 - $0.00
Close price
$8.20
Market cap
$639.1M
P/E ratio
3.85
Beta
0.8
About the company
Cormedix Inc
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$14.60
5
Buy
/ 5
Recent calls
10/20/2026
Leerink Partners
Roanna Ruiz
Buy · Price target $16.00
10/08/2026
RBC Capital
Leonid Timashev
Buy · Price target $14.00
09/23/2026
Oppenheimer
Unknown Analyst
Buy · Price target $15.00
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app